While our in vitro models provide valuable mechanistic insights into the role of METTL14 in the regulation of immune‐ and inflammation‐related genes, they inherently lack the complexity of the tumor microenvironment (TME) and the systemic interactions that occur in vivo. Here, METTL14 is linked to neoplasm.